SCHEMBL17632538

SCHEMBL17632538

N#CN(C(=O)[C@H]1CCNC1)c1nc2c(s1)CN(Cc1ccccc1)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.51
▸ GAA P10253 6/20 0.51
▸ MAPT P10636 5/20 0.51
▸ KDM4E B2RXH2 5/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ KMT2A Q03164 6/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ ROCK2 O75116 2/20 0.44
▸ MEN1 O00255 5/20 0.44
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ USP2 O75604 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17631972 0.83 GRM5 (0.51) —
SCHEMBL17632125 0.82 GRM5 (0.40) RAB9ANPC1KMT2A
SCHEMBL17631750 0.82 GRM5 (0.38) —
SCHEMBL17632276 0.81 F10 (0.41) KDM4ERAB9ANPC1ROCK2CYP2C19
SCHEMBL17632318 0.79 GRM5 (0.41) —
SCHEMBL17631678 0.79 GRM5 (0.41) ALDH1A1SMN1; SMN2
SCHEMBL17632587 0.78 NPC1 (0.40) RAB9ANPC1KMT2A
SCHEMBL17631404 0.77 TLR9 (0.39) ALDH1A1RAB9ANPC1
SCHEMBL17631978 0.77 GRM5 (0.41) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A
SCHEMBL17632462 0.77 FASN (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback